The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMycelx Di Regulatory News (MYX)

Share Price Information for Mycelx Di (MYX)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 65.00
Bid: 64.00
Ask: 66.00
Change: 0.00 (0.00%)
Spread: 2.00 (3.125%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 65.00
MYX Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Trading Update

15 Jan 2015 17:39

RNS Number : 3238C
MyCelx Technologies Corporation
15 January 2015
 

Not for release, publication or distribution directly or indirectly, in whole or in part, in or into or from the United States of America, its territories and possessions, any state of the United States, and the District of Columbia (collectively, the "United States"), Canada, Australia, the Republic of South Africa, the Republic of Ireland or Japan or any other jurisdiction where to do so would constitute a violation of the relevant laws of such jurisdiction.

 

This press release does not constitute or form a part of, and should not be construed as, any offer or invitation to sell or issue, or any solicitation of any offer to purchase or subscribe for, any securities in MYCELX Technologies Corporation ("MYCELX" or the "Company").

 

THE COMPANY'S COMMON SHARES HAVE NOT BEEN REGISTERED UNDER THE US SECURITIES ACT OF 1933, AS AMENDED (THE "US SECURITIES ACT") OR ANY STATE SECURITIES LAWS (THE "STATE ACTS") AND MAY NOT BE OFFERED OR SOLD IN THE UNITED STATES OR TO OR FOR THE ACCOUNT OR BENEFIT OF US PERSONS UNLESS THE SECURITIES ARE REGISTERED UNDER THE US SECURITIES ACT AND ANY APPLICABLE STATE ACTS, OR AN EXEMPTION FROM THE REGISTRATION REQUIREMENTS OF THE US SECURITIES ACT AND ANY APPLICABLE STATE ACTS IS AVAILABLE. HEDGING TRANSACTIONS INVOLVING THE COMPANY'S COMMON SHARES MAY NOT BE CONDUCTED UNLESS IN COMPLIANCE WITH THE US SECURITIES ACT.

 

 

MYCELX Technologies Corporation

 

("MYCELX" or the "Company") (AIM: MYX)

 

15 January 2015

 

2014 Year End Trading Update & Contract Wins

 

MYCELX Technologies Corporation (AIM: MYX), the clean water technology company providing patented solutions for commercial industrial markets worldwide, announces a trading update ahead of its 2014 Full Year Results, which will be announced on 20 March 2015.

 

The Company now expects to report full year revenue of $13.6 million for FY2014. This reduction in revenue results in a pre-tax loss of $5.7 million and an EBITDA of negative $4.2 million.

 

The Company had expected $1.8 million of revenue from an existing client on a stored waste water

project (lease, service and media). This contract has been delayed to coincide with operational maintenance expected in Q1 2015. An additional $450K of media revenue which was expected from a waste water project with a separate customer in December was not realized as the project was completed ahead of schedule due to lower than expected water volumes. The majority of the remaining shortfall resulted from end of year media sales forecasted from existing customers that did not occur.

 

Historically, the month of December has always been a strong one for revenue in the context of the Company's respective calendar year with clients spending surplus budgets for the year. This year we anticipated a similar trend. However, following our post year end analysis we believe that clients were reluctant to spend surplus budgets in response to the significant price declines in WTI and Brent prices in the last quarter of 2014. Such material moves in commodity prices, in conjunction with the significant sizes of certain contracts we are working on, makes forecasting extremely challenging.

 

 In reference to the three major projects that the Company has stated that it expects to execute in 2015, the Company has been awarded the contract for the short term waste water project. This is currently capped at $2.9 million. The Company is in discussions relating to the two larger projects and they remain active prospects. However, given the scale of the individual projects and the unpredictability of the timing of the project awards, the revenue forecast related to these projects has been revised downward for 2015. The Company has also received a $3.6 million contract for a lease renewal with one of its major customers in the Middle East.

 

The Company believes that given the uncertainty and extreme volatility surrounding the oil and gas industry it is not prudent to maintain its present revenue forecast for 2015. Therefore, the Company is revising its 2015 revenue to a range of $24 million to $29 million. Close attention and oversight of expenses is in place to assist EBITDA profitability at the lower end of the range.

 

Connie Mixon, CEO, commented:

 

"MYCELX will continue to provide long term value to the oil and gas industry. Cost effectively treating water associated with production and process will remain an important focus even in the difficult environment of volatile oil prices. The Company believes it should be profitable in 2015 by closely managing costs in line with revenue realized throughout the year and will continue to build its business for the future."

 

 

For further information please contact:

 

MYCELX Technologies Corporation

Connie Mixon, CEO

Mark Clark, CFO

+1 888 306 6843

 

Numis Securities Limited

Corporate Finance 

Stuart Skinner

Nathaniel Janks

+44 20 7260 1000

 

Corporate Broking

James Black

Ben Stoop

+44 20 7260 1000

Bell Pottinger

Nick Lambert

Henry Lerwill

+44 20 3772 2500

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTPKPDNOBKDFDD
Date   Source Headline
16th Mar 20167:00 amRNSAppointment of CFO/Grant of Share Options
4th Mar 20161:25 pmRNSHolding(s) in Company
4th Mar 20167:00 amRNSTrading Update
11th Jan 20165:30 pmRNSHolding(s) in Company
29th Dec 20152:23 pmRNSHolding(s) in Company
18th Dec 201510:13 amRNSHolding(s) in Company
15th Dec 20155:25 pmRNSHolding(s) in Company
15th Dec 20155:24 pmRNSHolding(s) in Company
11th Dec 20157:00 amRNSTrading Update
3rd Dec 201511:33 amRNSBlocklisting Interim Review
1st Oct 20157:00 amRNSProgress Update on Trials
10th Sep 20157:00 amRNSHalf Yearly Report
28th Aug 20157:00 amRNSRestricted Common Shares to be Traded in CREST
20th Aug 20157:00 amRNSDirector Resignation
17th Aug 20157:00 amRNSProgress Report on Trials and Cost Reduction
29th Jul 20152:01 pmRNSHolding(s) in Company
22nd Jul 20157:00 amRNSTrading Statement
1st Jul 20157:00 amRNSChange of Adviser
5th Jun 20157:00 amRNSDirector/PDMR Shareholding
28th May 20159:48 amRNSBlocklisting Interim Review
21st May 20153:01 pmRNSDirector/PDMR Shareholding
19th May 20154:01 pmRNSResult of Annual Meeting
19th May 20157:00 amRNSAnnual Meeting Statement
17th Apr 20157:00 amRNSMailing of 2014 Annual Report & Notice of AGM
20th Mar 20157:00 amRNS2014 Preliminary Results
15th Jan 20155:39 pmRNSTrading Update
5th Jan 20157:00 amRNSClose of US Placing
2nd Jan 201512:00 pmRNSHolding(s) in Company
22nd Dec 201412:54 pmRNSHolding(s) in Company
10th Dec 20147:00 amRNSEquity Placing
2nd Dec 20147:00 amRNSEquity Placing
27th Nov 20143:58 pmRNSBlocklisting Interim Review
19th Nov 20147:00 amRNSTrading Statement
12th Sep 20147:00 amRNSHalf Year Results Statement
26th Aug 20147:00 amRNSMiddle East Contract Win
7th Jul 20147:00 amRNSHalf Year Trading Update & Contract Wins
13th May 20143:31 pmRNSResult of Annual Meeting
29th Apr 20144:44 pmRNSBlocklisting Interim Review
22nd Apr 201410:02 amRNSAnnual Report & Accounts Posted
20th Mar 20147:00 amRNS2013 Preliminary Results
30th Jan 20147:00 amRNSYear End Trading Update & Contract Wins
10th Dec 20133:29 pmRNSTotal Voting Rights
4th Dec 20133:24 pmRNSHolding(s) in Company
26th Nov 20137:00 amRNSFast-to-market lease programme yields new leasings
30th Oct 20133:21 pmRNSDirector/PDMR Shareholding
29th Oct 20131:56 pmRNSBlocklisting Interim Review
16th Oct 20133:12 pmRNSDirector Shareholding / Warrant Exercise
3rd Oct 20137:00 amRNSInvestor Presentation
12th Sep 20137:00 amRNSHalf Year Results Statement
19th Aug 20139:06 amRNSNotice of Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.